Research Article| Volume 28, ISSUE 4, P349-357, August 15, 1990

Download started.


Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age

      This paper is only available as a PDF. To read, Please Download here.


      This study investigates the relationships between cortisol escape from suppression by dexamethasone during a depressive episode, and the baseline activity of the hypothalamic-pituitary-adrenal (HPA) axis, circulating dexamethasone levels, and age. To this end, we measured urinary-free cortisol (UFC) excretion in 24-hr urine samples and the 8 am cortisol and dexamethasone levels after administration of 1 mg dexamethasone in 50 depressive patients. We found that up to 54% of the variance in the postdexamethasone cortisol values could be explained by the multiple regression on UFC, age, and dexamethasone levels. By utilizing these three parameters, the dexamethasone suppression test (DST) nonsuppressor/suppressor state was correctly identified in 92% of the subjects. It was shown that an important part of the variance in postdexamethasone cortisol is actually background variance, irrelevant to depression and produced by the cumulative effects of the three aforementioned parameters. Only a small part (<20%) of the variance in postdexamethasone cortisol is determined by the actual depressive state. It was concluded that (1) baseline hypersecretion of cortisol, (2) decrements in the bicavailability of the test substance, (3) increasing age, and (4) the depressive state per se—all of which are cumulative—contribute independently to cortisol escape from suppression by 1 mg dexamethasone.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Aggernaes H.
        • Kirkegaard C.
        • Krog-Meyer I.
        • et al.
        Dexamethasone suppression test and TRH test in endogenous depressions.
        Acta Psychiatr Scand. 1983; 67: 258-264
        • Alexopoulos G.S.
        • Young R.C.
        • Kocsis J.H.
        • Brockner N.
        • Butler T.A.
        • Stokes P.E.
        Dexamethasone suppression test in geriatric depression.
        Biol Psychiatry. 1984; 19: 1567-1571
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        ed 3. American Psychiatric Association, Washington, DC1980
        • Asnis G.N.
        • Sachar E.J.
        • Dackis C.A.
        • Halbreich U.
        • Nathan R.S.
        • Halpern F.S.
        The dexamethasone suppression test (DST) and cortisol hypersecretion in endogenous depression (Abstract). Psychoneuroendocrinology Symposium. McMaster University, Hamilton, Ontario, Canada1981
        • Beisel W.R.
        • Cos J.J.
        • Horton R.
        • et al.
        Physiology of urinary cortisol excretion.
        J Clin Endocrinol Metab. 1964; 24: 887-893
        • Berger M.
        • Doerr P.
        • Lund R.
        • Bronisch T.
        • von Zerssen D.
        Neuroendocrinological and neurophysiological studies in major depressive disorders: Are there biological markers for the endogenous subtype?.
        Biol Psychiatry. 1982; 17: 1217-1242
        • Carr V.
        • Morris H.
        • Gilliland J.
        The effect of serum dexamethasone concentrations on the dexamethasone suppression test.
        Biol Psychiatry. 1986; 21: 735-743
        • Carroll B.J.
        Clinical application of neuroendocrine research in depression.
        in: van Praag H.M. Lader M.H. Rafaelsen O.J. Sachar E.J. Handbook of Biological Psychiatry, Part III: Brain Mechanisms and Abnormal Behavior-Genetics and Neuroendocrinology. Marcel Dekker, New York1980: 179-193
        • Carroll B.J.
        • Curtis G.C.
        • Mendels J.
        Neuroendocrine regulation in depression. II. Discrimination of depressed from non-depressed patients.
        Arch Gen Psychiatry. 1976; 33: 1051-1058
        • Eddy R.L.
        • Jones A.L.
        • Gilliland P.F.
        • et al.
        Cushing's syndrome: A prospective study of diagnostic methods.
        Am J Med. 1973; 55: 621-630
        • Feinberg M.
        • Carroll B.J.
        Biological ‘markers” for endogenous depression, effect of age, severity of illness, weight loss and polarity.
        Arch Gen Psychiatry. 1984; 41: 1080-1085
        • Hamilton M.
        A rating scale for depression.
        J Neurol Neurosurg Psychiatry. 1960; 23: 56-61
        • Holsboer F.
        • Doerr H.G.
        • Gerken A.
        • Muller O.A.
        • Sippell W.G.
        Cortisol, 11-deoxycortisol, and ACTH concentrations after dexamethasone in depressed patients and healthy volunteers.
        Psychiatry Res. 1984; 17: 15-23
        • Johnson G.F.
        • Hunt G.
        • Kerr K.
        • Caterson I.
        Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
        Psychiatry Res. 1984; 13: 305-313
        • Lewis D.A.
        • Pfohl B.
        • Schlechte J.
        • Coryell W.
        Influence of age on the cortisol response to dexamethasone.
        Psychiatry Res. 1984; 13: 213-220
        • Lowy M.T.
        • Meltzer H.Y.
        Dexamethasone availability: Implications for DST research.
        Biol Psychiatry. 1987; 22: 373-385
        • Maes M.
        • De Ruyter M.
        • Hobin P.
        • Suy E.
        The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depressive categories.
        J Affective Disord. 1986; 10: 207-214
        • Maes M.
        • De Ruyter M.
        • Hobin P.
        • Suy E.
        Repeated dexamethasone suppression test in depressed patients.
        J Affective Disord. 1986; 11: 165-172
        • Maes M.H.J.
        • De Ruyter M.
        • Suy E.
        Prediction of subtype and severity of depression by means of dexamethasone suppression test, L-tryptophan/competing amino acid ratio, and MHPG flow.
        Biol Psychiatry. 1987; 22: 177-188
        • Maes M.
        • De Ruyter M.
        • Suy E.
        Use of the dexamethasone suppression test in an inpatient setting: A replication and new findings.
        Psychoneuroendocrinology. 1989; 14: 231-239
        • Maes M.
        • Minner B.
        • Suy E.
        The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and the relationships between post-dexamethasone cortisol and ACTH levels.
        J Affective Disord. 1989; 17: 39-46
        • Maguire K.P.
        • Schweitzer I.
        • Biddle N.
        • Bridge S.
        • Tiller J.W.G.
        The dexamethasone suppression test: Importance of dexamethasone concentrations.
        Biol Psychiatry. 1987; 22: 957-967
        • Meikle A.W.
        Dexamethasone suppression tests: Usefulness of simultaneous measurements of plasma cortisol and dexamethasone.
        Clin Endocrinol. 1982; 16: 401-408
        • Morris H.
        • Carr V.
        • Gilliland J.
        • Hooper M.
        Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders.
        Br J Psychiatry. 1986; 148: 66-69
        • Oxenkrug G.F.
        • Pomara N.
        • McIntyre I.M.
        • Branconnier R.J.
        • Stanley M.
        • Gershon S.
        Aging and cortisol resistance to suppression by dexamethasone: A positive correlation.
        Psychiatry Res. 1983; 10: 125-130
        • Rosner J.M.
        • Cos J.J.
        • Biglieri E.G.
        Determination of urinary unconjugated cortisol by glass fiber chromatography in the diagnosis of Cushing's syndrome.
        J Clin Endocrinol Metab. 1963; 23: 820-827
        • Rubinow D.R.
        • Post R.M.
        • Gold P.W.
        • Ballenger J.C.
        • Wolff E.A.
        Neurobiology of Mood Disorders, Frontiers of Clinical Neuroscience. Vol. 1. Williams and Wilkins, Baltimore/London1984: 271-289
        • Sapolsky R.M.
        • McEwen B.S.
        • Nemeroff C.B.
        Why dexamethasone resistance? Two possible neuroendocrine mechanisms.
        in: Schatzberg A.F. The Hypothalamic-Pituitary-Adrrenal Axis. Raven Press, New York1988: 155-170
        • Spitzer R.L.
        • Williams J.B.W.
        • Gibbon M.
        Structured Clinical Interview for DSM-III Patient Version.
        Biometrics Research Department, New York State Psychiatric Institute, New York1985
        • Stangl D.
        • Pfohl B.
        • Zimmerman M.
        • Coryell M.
        • Corenthal C.
        The relationship between age and post-dexamethasone cortisol: A test of three hypotheses.
        J Affective Disord. 1986; 11: 185-197
        • Stokes P.E.
        • Stoll P.M.
        • Koslow S.H.
        • et al.
        Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups.
        Arch Gen Psychiatry. 1984; 41: 257-267
        • Vandewoude M.
        • De Leeuw I.
        Nutritional supportive care in head and neck surgery.
        Acta Oto-Rhinolaryngol. 1983; 37: 515-525
        • Wiedemann K.
        • Holsboer F.
        Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug.
        Biol Psychiatry. 1987; 22: 1340-1348
        • Williams J.B.W.
        • Spitzer R.L.
        Research Diagnostic Criteria and DSM-III: An annotated comparison.
        Arch Gen Psychiatry. 1982; 39: 1283-1289